← All organizations

Fondazione Epatocentro Ticino

Academic/Hospital

Also known as: Fondazione Epatocentro Ticino

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 3 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

methylene blue

Indications

Studied for

Influenza, Human

Recent trials (3)

NCT06887036Lead sponsorPhase 2Sep 30, 2025
NCT04635605Lead sponsorPhase 2Nov 30, 2020
NCT03699839CollaboratorPhase 2/Phase 3Oct 26, 2018

Details

Last known activity: Sep 30, 2025